ArticleBMJ open2022

Sodium-glucose cotransporter-2 inhibitors for improving endocrine and metabolic profiles in overweight and obese individuals with polycystic ovary syndrome: a meta-analysis protocol.

Jiaqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.